Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q1 FY26 results · Apr–Jun 2025
Unichem Laboratories reported revenue from operations of ₹526.60 crore (up 18.0% from Q1 FY25) and net loss of ₹10.47 crore for Q1 FY26 (Apr–Jun 2025), on a consolidated basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 526.60 | 446.43 | +18.0% | 587.18 | −10.3% |
| Other income | 6.82 | 3.86 | +76.7% | 9.25 | −26.3% |
| Total income | 533.42 | 450.29 | +18.5% | 596.43 | −10.6% |
| Profit before tax | (9.02) | 15.00 | Turned loss | 57.80 | Turned loss |
| Net profit for the period | (10.47) | 9.26 | Turned loss | 52.97 | Turned loss |
| EPS, basic (₹) | (1.49) | 1.31 | Turned loss | 7.52 | Turned loss |
| Net margin (%) | -2.0 | 2.1 | 9.0 |
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 384.25 | 389.75 | −1.4% | 461.24 | −16.7% |
| Other income | 4.25 | 8.77 | −51.6% | 6.05 | −29.8% |
| Total income | 388.50 | 398.52 | −2.5% | 467.29 | −16.9% |
| Profit before tax | (1.87) | 21.48 | Turned loss | 56.03 | Turned loss |
| Net profit for the period | (1.85) | 21.48 | Turned loss | 51.22 | Turned loss |
| EPS, basic (₹) | (0.26) | 3.05 | Turned loss | 7.28 | Turned loss |
| Net margin (%) | -0.5 | 5.5 | 11.1 |
Consolidated
- Filed with BSE
- 04 Aug 2025, 14:07 IST
- Board meeting
- 04 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 04 Aug 2025, 14:07 IST
- Board meeting
- 04 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE